Transgenomic Inc.

Transgenomic Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$585.89 M
Shares Outstanding
50.9 M
Public Float
24.52 M


29 Hartwell Avenue
Lexington Massachusetts 02421
United States
Employees -
Updated 07/08/2019
Translate Bio, Inc. engages in the research and development of therapeutic drugs. Its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases. The company was founded in 2011 and is headquartered in Cambridge, MA.


View All

Ronald C. Renaud
President, Chief Executive Officer & Director
John R. Schroer
Chief Financial Officer & Treasurer